NASDAQ:TBIO - Nasdaq - US1920032000 - Common Stock - Currency: USD
TTM (2024-6-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
---|---|---|---|---|---|---|---|---|
Revenue | 17.53M | 27.51M | 27.43M | 11.04M | 6.58M | |||
Cost Of Goods | 9.14M | 10.56M | 11.84M | 6.74M | 2.95M | |||
Gross Profit | 8.39M | 16.95M | 15.60M | 4.30M | 3.63M | |||
Operating Expenses | 43.60M | 52.10M | 62.08M | 39.67M | 19.99M | |||
Research and Development | 13.18M | 17.50M | 23.46M | 14.55M | 8.93M | |||
Selling, General, and Administrative Expenses | 30.42M | 34.60M | 38.62M | 25.13M | 11.06M | |||
Operating Income | -35.21M | -35.15M | -46.49M | -35.37M | -16.36M | |||
Interest Income/Expense | -651.00K | -1.03M | -1.21M | -2.89M | -1.57M | |||
Other Income/Expense | -231.00K | -130.00K | -26.00K | -62.00K | -74.00K | |||
Non Recurring Items | N/A | -11.39M | -727.00K | -618.00K | N/A | |||
Income Before Taxes | -48.50M | -47.70M | -48.45M | -38.94M | -18.00M | |||
Income Tax | 20.00K | 24.00K | 24.00K | 14.00K | 5.00K | |||
Net Income | -51.87M | -49.02M | -48.47M | -38.96M | -18.01M | |||
EBITDA | -32.87M | -32.83M | -44.81M | -34.47M | -15.49M | |||
Per Share Data | ||||||||
EPS Diluted Total Ops | -30.82 | -29.56 | -29.61 | -38.48 | -11.09 | |||
Non GAAP EPS | -23.94 | -11.45 | -1.65 | N/A | -0.81 | |||
Statistics | ||||||||
Gross Profit Margin | 47.88% | 61.62% | 56.84% | 38.93% | 55.12% | |||
Profit Margin | -295.86% | -178.21% | -176.68% | -352.78% | -273.87% | |||
Operating Profit Margin | -200.83% | -127.78% | -169.44% | -320.33% | -248.80% |
All data in USD